The Honest Company, Inc.
HNST · NASDAQ
Analyst ratings
buy · 3 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| February 26, 2026 | Telsey Advisory Group | Maintains | Market Perform | $3.00 |
| February 26, 2026 | Freedom Broker | Maintains | Buy | $3.00 |
| February 19, 2026 | Telsey Advisory Group | Maintains | Market Perform | $3.00 |
| November 19, 2025 | Morgan Stanley | Maintains | Equal-Weight | $3.00 |
| November 6, 2025 | Telsey Advisory Group | Maintains | Market Perform | $3.00 |
| October 30, 2025 | Telsey Advisory Group | Maintains | Market Perform | $6.00 |
Revenue trajectory: Growth recovery vs. continued decline
Several firms, including Morgan Stanley, Telsey Advisory, and Alliance Global, have raised their price targets, signaling renewed confidence in Honest Company's execution on core business fundamentals. Q1 2026 revenue of $78.10M beat analyst estimates of $76.25M, suggesting the company can outperform modest expectations.
Revenue declined from $378M in 2024 to $371.32M in 2025, and forward-looking models now project a further annual decline of approximately 4.2% over the next three years. Updated valuation work has also revised the revenue decline assumption only marginally, from -2.53% to -2.36%, indicating persistent structural headwinds.
Profitability and margin improvement sustainability
Operating cash flow improved to $15.12M and EPS has grown 89% over the last three years, pointing to meaningful operational progress. Analysts forecasting $0.1 EPS for the current year and a return on equity of 3.52% suggest the company is making tangible strides toward sustained profitability.
Despite some improvements, Honest Company maintains a deeply negative net margin of -5.39%, and updated analyst models slashed the net profit margin assumption from 6.19% to just 0.66%. Heavy reliance on marketing promotions and tariff exposure remain key risks that could further weigh on profitability.
Valuation: Justified premium vs. unsustainable elevated multiples
The fair value target has been lifted from $3.50 to $4.07 per share — a roughly 16% increase — reflecting refreshed analyst conviction around brand positioning and category extensions into flushable wipes, apparel, and personal care. This revised target implies meaningful upside from current trading levels.
The stock trades at an elevated P/E of 48.83x, implying high expectations that ongoing losses and revenue volatility make difficult to justify. The future P/E assumption in updated models has ballooned to 245.70x, raising concerns that the valuation is detached from near-term fundamental realities, with two analysts maintaining outright sell ratings.